A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

计划入组 95 人 · 首次发布于 2020 年 11 月 23 日

A Study of Donanemab (LY3002813) in Healthy Participants

计划入组 42 人 · 首次发布于 2022 年 10 月 5 日

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

计划入组 1,175 人 · 首次发布于 2023 年 2 月 22 日

Donanemab(Kisunla, 记能达)

Rx

Leukine Clinical Trial Explores Novel Alzheimer's Treatment

Alzheimer's Prevention Trials Update: Lecanemab, Donanemab, and Remternetug

Donanemab Recommendations Offer Guidance for Alzheimer's Treatment